Biovica International Ab Stock Price To Sales
| BIOVIC-B | SEK 1.87 0.07 3.89% |
Biovica International AB fundamentals help investors to digest information that contributes to Biovica International's financial success or failures. It also enables traders to predict the movement of Biovica Stock. The fundamental analysis module provides a way to measure Biovica International's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biovica International stock.
Biovica |
Biovica International AB Company Price To Sales Analysis
Biovica International's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Biovica International Price To Sales | 48.31 X |
Most of Biovica International's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biovica International AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Biovica International AB has a Price To Sales of 48.3114 times. This is 125.75% higher than that of the Healthcare sector and 50.91% lower than that of the Biotechnology industry. The price to sales for all Sweden stocks is notably lower than that of the firm.
Biovica Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biovica International's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biovica International could also be used in its relative valuation, which is a method of valuing Biovica International by comparing valuation metrics of similar companies.Biovica International is currently under evaluation in price to sales category among its peers.
Biovica Fundamentals
| Return On Equity | -0.65 | |||
| Return On Asset | -0.36 | |||
| Operating Margin | (14.77) % | |||
| Current Valuation | 175.91 M | |||
| Shares Outstanding | 39.47 M | |||
| Shares Owned By Institutions | 3.73 % | |||
| Price To Book | 2.26 X | |||
| Price To Sales | 48.31 X | |||
| Revenue | 2.04 M | |||
| Gross Profit | 4.73 M | |||
| EBITDA | (75.36 M) | |||
| Net Income | (60 M) | |||
| Cash And Equivalents | 89.79 M | |||
| Cash Per Share | 0.71 X | |||
| Total Debt | 8.78 M | |||
| Current Ratio | 2.56 X | |||
| Book Value Per Share | 2.86 X | |||
| Cash Flow From Operations | (52.13 M) | |||
| Earnings Per Share | (2.11) X | |||
| Target Price | 22.6 | |||
| Number Of Employees | 27 | |||
| Beta | 1.02 | |||
| Market Capitalization | 403.5 M | |||
| Total Asset | 151.63 M | |||
| Z Score | 27.0 | |||
| Net Asset | 151.63 M |
About Biovica International Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biovica International AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biovica International using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biovica International AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Biovica Stock
Biovica International financial ratios help investors to determine whether Biovica Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biovica with respect to the benefits of owning Biovica International security.